Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors

US9040558B2 · kind B2 · utility

Assignee

• DR. REDDY'S LABORATORIES LIMITED · IN

Inventors

• Anima Baruah · Hyderabad, IN
• Dibyendu De · Suwanee, US
• Ish Khanna · Vernon Hills, US
• Sivaram Pillarisetti · Norcross, US
• Santanu Maitra · Hyderabad, IN
• Christopher W. Alexander · Norcross, US
• Jennepalli Sreenu · Darsi, IN
• Indu Dager · Ghaziabad, IN
• Shanavas Alikunju · Darsi, IN

Key dates

• Filing date: Dec 28, 2005
• Grant date: May 26, 2015
• Expiry date: Apr 6, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D498/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention is directed to novel substituted benzylamino quinolines, compounds comprising substituted benzylamino quinolines, methods of making substituted benzylamino quinolines, the use of substituted benzylamino quinolines for treating or preventing a variety of conditions or diseases associated with lipoprotein metabolism, and the use of substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors.